These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11911017)

  • 1. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes.
    Ergün S; Kilic N; Wurmbach JH; Ebrahimnejad A; Fernando M; Sevinc S; Kilic E; Chalajour F; Fiedler W; Lauke H; Lamszus K; Hammerer P; Weil J; Herbst H; Folkman J
    Angiogenesis; 2001; 4(3):193-206. PubMed ID: 11911017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.
    Hajitou A; Grignet C; Devy L; Berndt S; Blacher S; Deroanne CF; Bajou K; Fong T; Chiang Y; Foidart JM; Noël A
    FASEB J; 2002 Nov; 16(13):1802-4. PubMed ID: 12354694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways.
    Eriksson K; Magnusson P; Dixelius J; Claesson-Welsh L; Cross MJ
    FEBS Lett; 2003 Feb; 536(1-3):19-24. PubMed ID: 12586331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
    Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
    Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antiangiogenic effect using 99mTc-EC-endostatin.
    Yang DJ; Kim KD; Schechter NR; Yu DF; Wu P; Azhdarinia A; Roach JS; Kalimi SK; Ozaki K; Fogler WE; Bryant JL; Herbst R; Abbruzzes J; Kim EE; Podoloff DA
    Cancer Biother Radiopharm; 2002 Apr; 17(2):233-45. PubMed ID: 12030117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
    Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
    J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
    Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
    FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
    Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay.
    Kruger EA; Duray PH; Tsokos MG; Venzon DJ; Libutti SK; Dixon SC; Rudek MA; Pluda J; Allegra C; Figg WD
    Biochem Biophys Res Commun; 2000 Feb; 268(1):183-91. PubMed ID: 10652234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
    Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA
    FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of full-length human endostatin on in vitro angiogenesis.
    Taddei L; Chiarugi P; Brogelli L; Cirri P; Magnelli L; Raugei G; Ziche M; Granger HJ; Chiarugi V; Ramponi G
    Biochem Biophys Res Commun; 1999 Sep; 263(2):340-5. PubMed ID: 10491294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
    Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
    Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.
    Bloch W; Huggel K; Sasaki T; Grose R; Bugnon P; Addicks K; Timpl R; Werner S
    FASEB J; 2000 Dec; 14(15):2373-6. PubMed ID: 11024009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sponge/Matrigel angiogenesis assay.
    Akhtar N; Dickerson EB; Auerbach R
    Angiogenesis; 2002; 5(1-2):75-80. PubMed ID: 12549862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release.
    Ma L; Elliott SN; Cirino G; Buret A; Ignarro LJ; Wallace JL
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6470-5. PubMed ID: 11353854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
    Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
    Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
    Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
    Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
    Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding.
    Yamaguchi N; Anand-Apte B; Lee M; Sasaki T; Fukai N; Shapiro R; Que I; Lowik C; Timpl R; Olsen BR
    EMBO J; 1999 Aug; 18(16):4414-23. PubMed ID: 10449407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.